Protara Therapeutics Inc. buy BiotechBee
Start price
13.11.24
/
70%
€2.52
Target price
31.10.26
€4.00
Performance (%)
112.30%
End price
14.12.24
€5.35
Summary
This prediction ended on 14.12.24 with a price of €5.35. With a performance of 112.30% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protara Therapeutics Inc. | 0.347% | 0.347% | 49.741% |
| iShares Core DAX® | 2,48 % | 1,74 % | 6,88 % |
| iShares Nasdaq 100 | -0,98 % | -2,74 % | 33,97 % |
| iShares Nikkei 225® | -4,89 % | 1,34 % | 57,02 % |
| iShares S&P 500 | 1,06 % | 0,05 % | 25,18 % |
According to BiotechBee what are the pros and cons of Protara Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Proteon Therapeutics Inc diskutieren
Buy mit Kursziel 4,0
In the thread Trading Protara Therapeutics Inc.
Buy beendet

